Requip
Overview
- About Requip
Special information if you are pregnant or breastfeeding
Although the effects of Requip during pregnancy have not been adequately studied in humans, birth defects have occurred in animals. If you are pregnant or plan to become pregnant, inform your doctor immediately.
Requip may inhibit production of breast milk. There is also a possibility that it will appear in breast milk and affect the nursing infant. If this medication is essential to your health, your doctor may advise you to discontinue breastfeeding.
Recommended dosage
ADULTS
Requip is taken 3 times a day. During the first week of therapy, each dose is 0.25 milligram. During the second week, the amount rises to 0.5 milligram. In the third week, it increases to 0.75 milligram, and in the fourth week reaches 1 milligram (3 milligrams daily). If necessary, your doctor will gradually increase the dosage further, up to a maximum of 24 milligrams per day.
If you need to stop Requip therapy, the doctor will discontinue the drug gradually over a 7-day period, reducing the number of doses from 3 to 2 per day for the first 4 days, then to once a day for the remaining 3 days.
Overdosage
Any medication taken in excess can have serious consequences. If you suspect an overdose, seek medical treatment immediately.
-
Symptoms of Requip overdose may include:
Agitation, chest pain, confusion, drowsiness, facial muscle movements, grogginess, increased jerkiness of movement, symptoms of low blood pressure (dizziness, light-headedness) upon standing, nausea, vomiting










